ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 243 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,458,000 | -17.9% | 74,855 | -6.0% | 0.04% | -10.4% |
| Q2 2021 | $5,432,000 | -25.6% | 79,641 | -24.3% | 0.05% | -32.4% |
| Q1 2021 | $7,302,000 | -8.8% | 105,229 | +1.0% | 0.07% | -21.1% |
| Q4 2020 | $8,005,000 | +45.6% | 104,197 | +41.7% | 0.09% | +11.1% |
| Q3 2020 | $5,498,000 | +14.7% | 73,514 | -3.5% | 0.08% | +26.6% |
| Q2 2020 | $4,795,000 | +25.3% | 76,168 | -16.4% | 0.06% | +8.5% |
| Q1 2020 | $3,826,000 | -21.8% | 91,094 | -15.5% | 0.06% | +55.3% |
| Q4 2019 | $4,894,000 | +0.5% | 107,754 | +1.3% | 0.04% | 0.0% |
| Q3 2019 | $4,871,000 | -19.6% | 106,419 | +2.9% | 0.04% | -15.6% |
| Q2 2019 | $6,061,000 | +13.3% | 103,382 | -13.4% | 0.04% | +18.4% |
| Q1 2019 | $5,350,000 | +20.3% | 119,334 | +4.5% | 0.04% | +8.6% |
| Q4 2018 | $4,447,000 | +10.6% | 114,179 | +30.8% | 0.04% | +34.6% |
| Q3 2018 | $4,019,000 | +29.9% | 87,326 | +23.0% | 0.03% | +30.0% |
| Q2 2018 | $3,095,000 | +48.9% | 70,994 | +35.0% | 0.02% | +17.6% |
| Q1 2018 | $2,078,000 | +40.8% | 52,602 | +21.0% | 0.02% | +70.0% |
| Q4 2017 | $1,476,000 | – | 43,460 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
| PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
| Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
| Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
| DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
| Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
| First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
| Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
| Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
| Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |